Liraglutide
Availability In clinic
What it is
Liraglutide is the first-generation GLP-1 receptor agonist, sold as Victoza for type 2 diabetes and Saxenda for weight management. It is the daily injection that the weekly drugs largely replaced. In August 2025 it became the first GLP-1 indicated for weight loss to face a generic, which changed its position in the market more than any trial result has.
Why people take it
Mostly price and access. When semaglutide or tirzepatide is unaffordable, unavailable, or uncovered, liraglutide is the approved GLP-1 that can still be had. It also carries a long real-world safety record, following its 2010 US approval, and its shorter duration of action appeals to prescribers starting someone whose tolerance is unknown, since a bad week ends sooner.
How it's delivered
A daily subcutaneous injection from a pen, titrated upward over weeks. Daily dosing is the main complaint against it now that weekly options exist. Nausea, vomiting, and constipation follow the same pattern as the rest of the class, concentrated during the climb to the target dose.
Where the evidence stands
Real, and modest by current standards. In the SCALE program, liraglutide produced roughly 8 percent body weight loss at 56 weeks against about 2.6 percent on placebo. LEADER, in people with type 2 diabetes at high cardiovascular risk, found fewer cardiovascular deaths and events, which remains the strongest outcome evidence liraglutide carries. Head to head, semaglutide beat it decisively for weight loss, and tirzepatide sits higher still, which is why liraglutide is now chosen for reasons other than efficacy. No trial has tested it for lifespan or aging in people without a metabolic indication, and weight returns after stopping.
Estimated cost
- $400–$1,200/mogeneric, by pharmacy and dose
- Around $1,300/mo brand-name Saxenda
- Discount-card pricing seen near $226 for two pens
- Prescription required
- Coverage for weight management is inconsistent
Who offers it
- TelehealthAgelessRx
- TelehealthDefy Medical
Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.
Go deeper
The full guide, How to start GLP-1s, covers how the drugs in this family compare and what starting one actually involves.
Longevity.io is for educational purposes only and is not medical advice. Whether liraglutide belongs in your plan is a conversation for a clinician who knows your situation. Confirm eligibility, services, and pricing directly with any provider.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
